Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials
- 2 May 2019
- journal article
- review article
- Published by Elsevier BV in The Lancet
- Vol. 393 (10190), 2503-2510
- https://doi.org/10.1016/s0140-6736(19)30474-x
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Trends in Cause of Death After Percutaneous Coronary InterventionCirculation, 2014
- Two-Year Outcomes After First- or Second-Generation Drug-Eluting or Bare-Metal Stent Implantation in All-Comer Patients Undergoing Percutaneous Coronary InterventionJACC: Cardiovascular Interventions, 2014
- Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysisThe Lancet, 2012
- 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and InterventionsJournal of the American College of Cardiology, 2011
- Comparison of Angioplasty With Infusion of Tirofiban or Abciximab and With Implantation of Sirolimus-Eluting or Uncoated Stents for Acute Myocardial InfarctionThe MULTISTRATEGY Randomized TrialJAMA, 2008
- Late Coronary Stent ThrombosisCirculation, 2007
- Bare metal stent restenosis is not a benign clinical entityAmerican Heart Journal, 2006
- Tirofiban and Sirolimus-Eluting Stent vs Abciximab and Bare-Metal Stent for Acute Myocardial InfarctionJAMA, 2005
- Statistics Notes: Interaction revisited: the difference between two estimatesBMJ, 2003
- Quantifying heterogeneity in a meta-analysisStatistics in Medicine, 2002